| Literature DB >> 27006314 |
Manolis Vavuranakis1, Konstantinos Kalogeras2, Dimitrios Tousoulis2.
Abstract
The application of transcatheter aortic valve implantation (TAVI) in a wider and younger population in the near future makes the need to successfully deal with challenging procedural conditions an imperative. We report a case in which TAVI was successfully conducted in a patient with aortic coarctation using a last-generation low-profile bioprosthesis. Despite the fragile aortic wall and its possible abnormal function, a low-profile (14F) CoreValve Evolute R device (Medtronic, Minneapolis, MN) was implanted through the coarctation without complications. Last-generation, low-profile transcatheter implanted aortic valves provide an additional advantage in patients with structural impediments. Copyright ÂEntities:
Mesh:
Year: 2016 PMID: 27006314 DOI: 10.1016/j.cjca.2016.01.021
Source DB: PubMed Journal: Can J Cardiol ISSN: 0828-282X Impact factor: 5.223